Trials Sponsors Conditions Drugs Pricing

Conditions

Chronic Kidney Diseases

Outcome Measures

Primary Outcomes (1)

Time to initiation of dialysis
Time to initiation of dialysis (scheduled and unscheduled) for participants with stage V chronic kidney disease and one or more comorbidities.
Up to 24 months

Study Arms (2)

"1 Minute for My Kidneys" App

EXPERIMENTAL

Participants in the experimental group will be monitored, in addition to receiving standard care, using the "1 Minute for My Kidneys" app. In addition, they will be required to complete a quality-of-life questionnaire (EQ-5D-5L, available directly in the app) once every 3 months.

Drug: Dialysis

Control group with quality of life

ACTIVE COMPARATOR

In addition to their usual care, participants in the control group will be asked to complete a questionnaire on quality of life during their nephrology appointment once every three months.

Drug: Dialysis

Interventions

DialysisDrug

Dialysis for a patient with stage V chronic kidney disease

"1 Minute for My Kidneys" AppControl group with quality of life

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age ≥ 18 and ≤ 80;
Participants with stage V chronic kidney disease;

Sponsors & Collaborators

Euraxi Pharma
Industrycollaborator
GCS Ramsay Santé pour l'Enseignement et la Recherche
Otherlead

Study Sites (1)

Hôpital Privé La Louvière

Lille, 59800, France

Maxime HOFFMANN, MDCONTACTmaxime.hoffmann@gmail.com

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Dialysis

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Maxime HOFFMANN
Hôpital Privé La Louvière
PRINCIPAL INVESTIGATOR

Central Study Contacts

Maxime HOFFMANN, MD

CONTACT

6 86 70 91 23 maxime.hoffmann@gmail.com

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Masking Details: Open-label clinical investigation
Purpose: OTHER
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 2, 2026

First Posted

October 13, 2026

Study Start

November 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

A Minute for my Kidneys

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

"1 Minute for My Kidneys" App

Control group with quality of life

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

"1 Minute for My Kidneys" App

Control group with quality of life

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Intervention Hierarchy (Ancestors)

Source record

Locations